young melanoma family facebook intervention or healthy lifestyle facebook intervention in improving skin examination in participants with melanoma and their families

Conditions: Clinical Stage 0 Cutaneous Melanoma AJCC v8; Clinical Stage I Cutaneous Melanoma AJCC v8; Clinical Stage IA Cutaneous Melanoma AJCC v8; Clinical Stage IB Cutaneous Melanoma AJCC v8; Clinical Stage II Cutaneous Melanoma AJCC v8; Clinical Stage IIA Cutaneous Melanoma AJCC v8; Clinical Stage IIB Cutaneous Melanoma AJCC v8; Clinical Stage IIC Cutaneous Melanoma AJCC v8; Clinical Stage III Cutaneous Melanoma AJCC v8; First Degree Relative; Pathologic Stage 0 Cutaneous Melanoma AJCC v8; Pathologic Stage I Cutaneous Melanoma AJCC v8; Pathologic Stage IA Cutaneous Melanoma AJCC v8; Pathologic Stage IB Cutaneous Melanoma AJCC v8; Pathologic Stage II Cutaneous Melanoma AJCC v8; Pathologic Stage IIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIC Cutaneous Melanoma AJCC v8; Pathologic Stage III Cutaneous Melanoma AJCC v8; Pathologic Stage IIIA Cutaneous Melanoma AJCC v8; Pathologic Stage IIIB Cutaneous Melanoma AJCC v8; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8

Summary: this trial studies how well young melanoma family facebook intervention or healthy lifestyle facebook intervention works in improving skin examination in participants with melanoma and their families. young melanoma family facebook intervention or healthy lifestyle facebook intervention may help improve total cutaneous examinations, skin self-examinations, and sun protection among first degree relatives of young onset participants and the participants themselves.

primary objectives: i. to examine the efficacy of the young melanoma family facebook intervention versus the healthy lifestyle facebook intervention on total cutaneous exam (primary outcome), skin self-exam frequency and comprehensiveness, and sun protection practices (secondary outcomes) of first degree relatives (fdrs) of young melanoma survivors. secondary objectives: i. to examine the efficacy of the young melanoma family facebook intervention on patients? skin self-exam frequency and comprehensiveness and sun protection habits. ii. to examine the mechanisms of intervention efficacy. outline: phase i: researchers refine content for the facebook intervention condition and conduct usability testing. phase ii: participants are randomized to 1 of 2 arms. arm i: participants join a secret young melanoma family facebook group and view post messages focusing on skin cancer for 12 weeks. arm ii: participants join a secret healthy lifestyle facebook group and view post messages focusing on healthy lifestyle for 12 weeks. phase iii: dissemination planning. after completion of study, participants are followed up at 6 months.

Eligibility criteria:
inclusion criteria: * patient: diagnosed with stage 0-3 melanoma in the last 5 years * patient: age at diagnosis 18-39 years * patient: completed treatment at least 3 months previously * patient: recruited from new jersey or california state cancer registry or md anderson cancer center * patient: does not have a concurrent cancer diagnosis * patient: able to speak and read english * patient: access to computer, internet, and has a facebook account * patient: at least one family member consents * fdr: current age 18-80 years * fdr: does not have a personal history of melanoma * fdr: able to speak and read english * fdr: access to computer, internet, and has a facebook account * fdr: has only one fdr with melanoma (patient) * fdr: has not had a total cutaneous examination (tce) in the past 3 years, has done skin self-exam (sse) fewer than three times in the past year, or has a sun protection habits average score less than or equal to 4 (?often?) * fdr: patient consents exclusion criteria: * physical activity readiness questionnaire (thomas, et. al., 1992): this 7-item scale will be used to screen out individuals who will need to consult a physician for medical clearance before engaging in physical activity. if a participant checks off any of the items, the investigators will ask for a physician clearance before consenting to study